Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy

British Journal of Ophthalmology

Volumn 80, Issue 2, 1996, Pages 117-124

  Char, Devron H ^a   Kroll, Stew ^a   Quivey, Jeanne M ^a   Castro, Joseph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIUM; IODINE 125;

ADULT; AGE; AGED; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CILIARY BODY; ENUCLEATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE; PRIORITY JOURNAL; RETINA FOVEA; RETROSPECTIVE STUDY; THICKNESS; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME; UVEA MELANOMA; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0030062421     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.2.117     Document Type: Article

References (26)

1. Seddon JM, Gragoudas ES, Albert DM, Hsieh CC, Polyvogianis L, Friedenberg GR. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol 1995; 99: 282-90.
2. Lommatzsch PK. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years' experience. Br J Ophthalmol 1986; 70: 844-51.
3. Augsburger JJ, Gamel JW, Sardi VF, Greenberg RA, Shields JA, Brady LW. Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol 1986; 104: 655-61.
4. Gragoudas ES, Seddon JM, Egan K, Glynn R, Munzenrider J, Austin-Seymour M, et al. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology 1987; 94: 349-53.
5. Adams KS, Abramson DH, Ellsworth RM, Haik BG, Bedford M, Packer S, et al. Cobalt plaque versus enucleation for uveal melanoma: comparison of survival rates. Br J Ophthalmol 1988; 72: 494-7.
6. DePotter P, Shields CL, Shields JA, Cater JM, Tardis DJ. Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival. Br J Ophthalmol 1994; 78: 109-14.
7. COMS. Design and methods of a clinical trial for a rare condition: the collaborative ocular melanoma study. Controlled Clinical Trials 1993; 14: 362-91.
8. Char DH, Castro JR, Kroll SM, Irvine AR, Quivey JM, Stone RD. Five year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol 1990; 108: 209-14.
9. Shields JA, Gragoudas ES, Char DH. Comments on management of uveal melanomas: a continuing dilemma. Cancer 1994; 74: 3074-5.
10. Seddon JM, Gragoudas ES, Polivogianis L, Hsieh CC, Egan K, Goitein M, et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology 1986; 93: 666-74.
11. Char DH, Quivey JM, Castro J, Kroll S, Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma: a prospective randomized, dynamically balanced trial. Ophthalmology 1993; 100: 1547-54.
12. Cruess AF, Augsburger JJ, Shields JA, Donoso L, Amsel J. Visual results following cobalt plaque radiotherapy for posterior uveal melanomas. Ophthalmology 1984; 91: 131-6.
13. Char DH, Stone RD, Irvine AR, Crawford JB, Hilton GF, Schwartz A. Diagnostic modalities in choroidal melanoma. Am J Ophthalmol 1980; 89: 223-30.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
15. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972; 34: 187-220.
16. Kalbfleisch J, Prentice RL. The statistical analysis of failure time data. New York: Wiley, 1980.
17. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical models based on counting processes. New York: Springer-Verlag, 1993.
18. Hill A, Maguire M, Hawkins BS, Newhouse MM. The Markov process as a general method for nonparametric analysis of right-censored medical data. J Chron Dis 1986; 39: 595-604.
19. Samuelsen SO, Kongerud J. Interval censoring in longitudinal data of respiratory symptoms in aluminum potroom workers: a comparison of methods. Stat Med 1994; 13: 1771-80.
20. Caplan RJ, Pajak TF, Cox JD. Analysis of the probability and risk of cause-specific failure. Int J Rad Onc Biol Phys 1994; 29: 1183-6.
21. Young LH, Gragoudas ES. Macular uveal melanoma treated with proton beam irradiation. 10-year follow-up observation with histopathologic correlation. Retina 1994; 14: 43-6.
22. Meecham WJ, Char DH, Kroll SM, Collier M, Castro JR. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract. Arch Ophthalmol 1994; 112: 197-203.
23. Fine SL. Do I take the eye out or leave it in? Arch Ophthalmol 1986; 104: 653-4.
24. Butler P, Char DH, Zarbin M, Kroll S. Natural history of indeterminant pigmented choroidal tumors. Ophthalmology 1994; 101: 710-6.
25. Augsburger JJ, Goel SD. Visual function following enucleation or episcleral plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 1994; 112: 786-9.
26. Edwards MG, Schachat AP. Impact of enucleation for choroidal melanoma on the performance of vision-dependent activities. Arch Ophthalmol 1991; 109: 519-21.